Home

Kofferraum Begleiter diagonal vans leuko timi Bruch Startseite Handbuch

Frontiers | Mild Therapeutic Hypothermia Alters Hemostasis in ST Elevation  Myocardial Infarction Patients
Frontiers | Mild Therapeutic Hypothermia Alters Hemostasis in ST Elevation Myocardial Infarction Patients

High Levels of Platelet Inhibition With Abciximab Despite Heightened  Platelet Activation and Aggregation During Thrombolysis for
High Levels of Platelet Inhibition With Abciximab Despite Heightened Platelet Activation and Aggregation During Thrombolysis for

Inflammatory Biomarkers in Acute Coronary Syndromes | Circulation
Inflammatory Biomarkers in Acute Coronary Syndromes | Circulation

Coronary leukocyte activation in relation to progression of coronary artery  disease
Coronary leukocyte activation in relation to progression of coronary artery disease

Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial  Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction  Undergoing Primary Percutaneous Coronary Intervention: An Observational  Study. - Abstract - Europe PMC
Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study. - Abstract - Europe PMC

TIMI Frame Count | Circulation
TIMI Frame Count | Circulation

JPM | Free Full-Text | MiR-126-3p and MiR-223-3p as Biomarkers for  Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction  and Primary Angioplasty
JPM | Free Full-Text | MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient,  Bedside, Clinical Score for Risk Assessment at Presentation | Circulation
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation | Circulation

Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial  Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction  Undergoing Primary Percutaneous Coronary Intervention: An Observational  Study. - Abstract - Europe PMC
Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study. - Abstract - Europe PMC

Local Recruitment of LFA-1 Lymphocytes After Coronary Stent Implantation
Local Recruitment of LFA-1 Lymphocytes After Coronary Stent Implantation

Sex differences in leukocyte profile in ST-elevation myocardial infarction  patients | Scientific Reports
Sex differences in leukocyte profile in ST-elevation myocardial infarction patients | Scientific Reports

Thrombus Structural Composition in Cardiovascular Disease |  Arteriosclerosis, Thrombosis, and Vascular Biology
Thrombus Structural Composition in Cardiovascular Disease | Arteriosclerosis, Thrombosis, and Vascular Biology

Cells | Free Full-Text | Monitoring NLRP3 Inflammasome Activation and  Exhaustion in Clinical Samples: A Refined Flow Cytometry Protocol for ASC  Speck Formation Measurement Directly in Whole Blood after Ex Vivo  Stimulation
Cells | Free Full-Text | Monitoring NLRP3 Inflammasome Activation and Exhaustion in Clinical Samples: A Refined Flow Cytometry Protocol for ASC Speck Formation Measurement Directly in Whole Blood after Ex Vivo Stimulation

Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor  AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR  study - International Journal of Cardiology
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study - International Journal of Cardiology

Fundamentals of Reperfusion Injury for the Clinical Cardiologist |  Circulation
Fundamentals of Reperfusion Injury for the Clinical Cardiologist | Circulation

The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as  innate amplifier of infection, autoimmunity, and cancer - Ehrchen - 2009 -  Journal of Leukocyte Biology - Wiley Online Library
The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer - Ehrchen - 2009 - Journal of Leukocyte Biology - Wiley Online Library

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN  Clinical Practice Guidelines in Oncology in: Journal of the National  Comprehensive Cancer Network Volume 19 Issue 10 (2021)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 10 (2021)

Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in  Myocardial Infarction and in Chronic Kidney Disease | Circulation
Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease | Circulation

Biomolecules | Free Full-Text | Nourin-Dependent miR-137 and miR-106b:  Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients
Biomolecules | Free Full-Text | Nourin-Dependent miR-137 and miR-106b: Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients

TIMI Frame Count | Circulation
TIMI Frame Count | Circulation

Monocyte count to high-density lipoprotein cholesterol ratio (MHR)... |  Download Scientific Diagram
Monocyte count to high-density lipoprotein cholesterol ratio (MHR)... | Download Scientific Diagram

Frontiers | ​Circulating Cytokines in Myocardial Infarction Are Associated  With Coronary Blood Flow
Frontiers | ​Circulating Cytokines in Myocardial Infarction Are Associated With Coronary Blood Flow

Full article: The balance of omega-3 polyunsaturated fatty acids for  -reducing residual risks in patients with coronary artery disease
Full article: The balance of omega-3 polyunsaturated fatty acids for -reducing residual risks in patients with coronary artery disease

Usefulness of the RISK-PCI score to predict stent thrombosis in patients  treated with primary percutaneous coronary intervention for ST-segment  elevation myocardial infarction: a substudy of the RISK-PCI trial |  SpringerLink
Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial | SpringerLink

GDF-15 is an inhibitor of leukocyte integrin activation required for  survival after myocardial infarction in mice | Nature Medicine
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice | Nature Medicine

Cathepsin S Levels and Survival Among Patients With Non-ST-Segment  Elevation Acute Coronary Syndromes - ScienceDirect
Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes - ScienceDirect

Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and  In-Hospital MACE in Patients With STEMI Undergoing Primary PCI - Turgay  Celik, Mehmet G. Kaya, Mahmut Akpek, Mikail Yarlioglues, Bahadir Sarli,
Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI - Turgay Celik, Mehmet G. Kaya, Mahmut Akpek, Mikail Yarlioglues, Bahadir Sarli,